Response to aflibercept as secondary therapy in patients with persistent retinal edema due to central retinal vein occlusion initially treated with bevacizumab or ranibizumab.

PubMed ID: 24999721 Author(s): Eadie JA, Ip M</strong>S, Kulkarni AD. Response to aflibercept as secondary therapy in patients with persistent retinal edema due to central retinal vein occlusion initially treated with bevacizumab or ranibizumab. Retina. …

A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides.

PubMed ID: 18474771 Author(s): Albert D</strong>M, Gangnon RE, Grossniklaus HE, Green WR, Darjatmoko S</strong>, Kulkarni AD. A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides. Arch Ophthalmol. 2008 …